001     1008582
005     20231027114408.0
024 7 _ |a 10.1111/cge.14352
|2 doi
024 7 _ |a 0009-9163
|2 ISSN
024 7 _ |a 1399-0004
|2 ISSN
024 7 _ |a 10.34734/FZJ-2023-02415
|2 datacite_doi
024 7 _ |a 37157876
|2 pmid
024 7 _ |a WOS:000985098200001
|2 WOS
037 _ _ |a FZJ-2023-02415
082 _ _ |a 610
100 1 _ |a Stalke, Amelie
|0 0000-0002-8438-8692
|b 0
|e Corresponding author
245 _ _ |a Functional characterization of novel or yet uncharacterized ATP7B missense variants detected in patients with clinical Wilson's disease
260 _ _ |a Malden, Mass.
|c 2023
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1692961738_31766
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Wilson's disease (WD, MIM#277900) is an autosomal recessive disorder resulting in copper excess caused by biallelic variants in the ATP7B gene (MIM#606882) encoding a copper transporting P-type ATPase. ATP7B variants of unknown significance (VUS) are detected frequently, sometimes impeding a clear diagnosis. Functional analyses can help to classify these variants as benign or pathogenic. Additionally, variants already classified as (likely) pathogenic benefit from functional analyses to understand their pathomechanism, thus contribute to the development of personalized treatment approaches in the future. We described clinical features of six WD patients and functionally characterized five ATP7B missense variants (two VUS, three yet uncharacterized likely pathogenic variants), detected in these patients. We determined the protein level, copper export capacity, and cellular localization in an in vitro model and potential structural consequences using an ATP7B protein model based on AlphaFold. Our analyses give insight into the pathomechanism and allowed reclassification for the two VUS to likely pathogenic and for two of the three likely pathogenic variants to pathogenic
536 _ _ |a 2171 - Biological and environmental resources for sustainable use (POF4-217)
|0 G:(DE-HGF)POF4-2171
|c POF4-217
|f POF IV
|x 0
536 _ _ |a DFG project 433387263 - Next-Generation Sequencing und funktionelle Charakterisierung von Varianten unklarer Signifikanz in pädiatrischen Hepatopathien (433387263)
|0 G:(GEPRIS)433387263
|c 433387263
|x 1
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Behrendt, Annika
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Hennig, Finja
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Gohlke, Holger
|0 P:(DE-Juel1)172663
|b 3
|u fzj
700 1 _ |a Buhl, Nicole
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Reinkens, Thea
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Baumann, Ulrich
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Schlegelberger, Brigitte
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Illig, Thomas
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Pfister, Eva-Doreen
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Skawran, Britta
|0 P:(DE-HGF)0
|b 10
773 _ _ |a 10.1111/cge.14352
|g p. cge.14352
|0 PERI:(DE-600)2004581-5
|n 2
|p 174-185
|t Clinical genetics
|v 104
|y 2023
|x 0009-9163
856 4 _ |u https://juser.fz-juelich.de/record/1008582/files/Clinical%20Genetics%20-%202023%20-%20Stalke.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:1008582
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)172663
913 1 _ |a DE-HGF
|b Forschungsbereich Erde und Umwelt
|l Erde im Wandel – Unsere Zukunft nachhaltig gestalten
|1 G:(DE-HGF)POF4-210
|0 G:(DE-HGF)POF4-217
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-200
|4 G:(DE-HGF)POF
|v Für eine nachhaltige Bio-Ökonomie – von Ressourcen zu Produkten
|9 G:(DE-HGF)POF4-2171
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-22
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2022-11-22
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-22
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CLIN GENET : 2022
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-22
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-22
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-22
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBG-4-20200403
|k IBG-4
|l Bioinformatik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBG-4-20200403
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21